The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pendred Syndrome-Global Market Insights and Sales Trends 2024
Synopsis
Pendred is defined as a rare inherited genetic disorder which is caused by mutations in a gene called SLC26A4 (formerly known as the PDS gene) on chromosome 7. It is categorized by bilateral sensorineural hearing loss and euthyroid goitre. This syndrome affects the body’s ability to make protein called pendrin, which is essential for normal function of inner ear and thyroid.
The global Pendred Syndrome market size is expected to reach US$ 1836.2 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Pendred Syndrome in various end use industries. The expanding demands from the Hospitals, Homecare, Specialty Clinics and Others, are propelling Pendred Syndrome market. Medicine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Implants segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pendred Syndrome, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pendred Syndrome market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pendred Syndrome market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pendred Syndrome sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pendred Syndrome covered in this report include Nobel Pharma, Sensorion, MED-EL Medical Electronics, Cochlear, Sonova, Amplifon, Demant, Nurotron Biotechnology and GN Store Nord, etc.
The global Pendred Syndrome market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Nobel Pharma
Sensorion
MED-EL Medical Electronics
Cochlear
Sonova
Amplifon
Demant
Nurotron Biotechnology
GN Store Nord
Audina Hearing Instruments
Rion
Starkey
Global Pendred Syndrome market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pendred Syndrome market, Segment by Type:
Medicine
Implants
Others
Global Pendred Syndrome market, by Application
Hospitals
Homecare
Specialty Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pendred Syndrome companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Pendred is defined as a rare inherited genetic disorder which is caused by mutations in a gene called SLC26A4 (formerly known as the PDS gene) on chromosome 7. It is categorized by bilateral sensorineural hearing loss and euthyroid goitre. This syndrome affects the body’s ability to make protein called pendrin, which is essential for normal function of inner ear and thyroid.
The global Pendred Syndrome market size is expected to reach US$ 1836.2 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Pendred Syndrome in various end use industries. The expanding demands from the Hospitals, Homecare, Specialty Clinics and Others, are propelling Pendred Syndrome market. Medicine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Implants segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pendred Syndrome, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pendred Syndrome market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pendred Syndrome market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pendred Syndrome sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pendred Syndrome covered in this report include Nobel Pharma, Sensorion, MED-EL Medical Electronics, Cochlear, Sonova, Amplifon, Demant, Nurotron Biotechnology and GN Store Nord, etc.
The global Pendred Syndrome market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Nobel Pharma
Sensorion
MED-EL Medical Electronics
Cochlear
Sonova
Amplifon
Demant
Nurotron Biotechnology
GN Store Nord
Audina Hearing Instruments
Rion
Starkey
Global Pendred Syndrome market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pendred Syndrome market, Segment by Type:
Medicine
Implants
Others
Global Pendred Syndrome market, by Application
Hospitals
Homecare
Specialty Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pendred Syndrome companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pendred Syndrome
1.1 Pendred Syndrome Market Overview
1.1.1 Pendred Syndrome Product Scope
1.1.2 Pendred Syndrome Market Status and Outlook
1.2 Global Pendred Syndrome Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pendred Syndrome Market Size by Region (2018-2029)
1.4 Global Pendred Syndrome Historic Market Size by Region (2018-2023)
1.5 Global Pendred Syndrome Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pendred Syndrome Market Size (2018-2029)
1.6.1 North America Pendred Syndrome Market Size (2018-2029)
1.6.2 Europe Pendred Syndrome Market Size (2018-2029)
1.6.3 Asia-Pacific Pendred Syndrome Market Size (2018-2029)
1.6.4 Latin America Pendred Syndrome Market Size (2018-2029)
1.6.5 Middle East & Africa Pendred Syndrome Market Size (2018-2029)
2 Pendred Syndrome Market by Type
2.1 Introduction
2.1.1 Medicine
2.1.2 Implants
2.1.3 Others
2.2 Global Pendred Syndrome Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pendred Syndrome Historic Market Size by Type (2018-2023)
2.2.2 Global Pendred Syndrome Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pendred Syndrome Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pendred Syndrome Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pendred Syndrome Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pendred Syndrome Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pendred Syndrome Revenue Breakdown by Type (2018-2029)
3 Pendred Syndrome Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Homecare
3.1.3 Specialty Clinics
3.1.4 Others
3.2 Global Pendred Syndrome Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pendred Syndrome Historic Market Size by Application (2018-2023)
3.2.2 Global Pendred Syndrome Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pendred Syndrome Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pendred Syndrome Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pendred Syndrome Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pendred Syndrome Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pendred Syndrome Revenue Breakdown by Application (2018-2029)
4 Pendred Syndrome Competition Analysis by Players
4.1 Global Pendred Syndrome Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pendred Syndrome as of 2022)
4.3 Date of Key Players Enter into Pendred Syndrome Market
4.4 Global Top Players Pendred Syndrome Headquarters and Area Served
4.5 Key Players Pendred Syndrome Product Solution and Service
4.6 Competitive Status
4.6.1 Pendred Syndrome Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Nobel Pharma
5.1.1 Nobel Pharma Profile
5.1.2 Nobel Pharma Main Business
5.1.3 Nobel Pharma Pendred Syndrome Products, Services and Solutions
5.1.4 Nobel Pharma Pendred Syndrome Revenue (US$ Million) & (2018-2023)
5.1.5 Nobel Pharma Recent Developments
5.2 Sensorion
5.2.1 Sensorion Profile
5.2.2 Sensorion Main Business
5.2.3 Sensorion Pendred Syndrome Products, Services and Solutions
5.2.4 Sensorion Pendred Syndrome Revenue (US$ Million) & (2018-2023)
5.2.5 Sensorion Recent Developments
5.3 MED-EL Medical Electronics
5.3.1 MED-EL Medical Electronics Profile
5.3.2 MED-EL Medical Electronics Main Business
5.3.3 MED-EL Medical Electronics Pendred Syndrome Products, Services and Solutions
5.3.4 MED-EL Medical Electronics Pendred Syndrome Revenue (US$ Million) & (2018-2023)
5.3.5 Cochlear Recent Developments
5.4 Cochlear
5.4.1 Cochlear Profile
5.4.2 Cochlear Main Business
5.4.3 Cochlear Pendred Syndrome Products, Services and Solutions
5.4.4 Cochlear Pendred Syndrome Revenue (US$ Million) & (2018-2023)
5.4.5 Cochlear Recent Developments
5.5 Sonova
5.5.1 Sonova Profile
5.5.2 Sonova Main Business
5.5.3 Sonova Pendred Syndrome Products, Services and Solutions
5.5.4 Sonova Pendred Syndrome Revenue (US$ Million) & (2018-2023)
5.5.5 Sonova Recent Developments
5.6 Amplifon
5.6.1 Amplifon Profile
5.6.2 Amplifon Main Business
5.6.3 Amplifon Pendred Syndrome Products, Services and Solutions
5.6.4 Amplifon Pendred Syndrome Revenue (US$ Million) & (2018-2023)
5.6.5 Amplifon Recent Developments
5.7 Demant
5.7.1 Demant Profile
5.7.2 Demant Main Business
5.7.3 Demant Pendred Syndrome Products, Services and Solutions
5.7.4 Demant Pendred Syndrome Revenue (US$ Million) & (2018-2023)
5.7.5 Demant Recent Developments
5.8 Nurotron Biotechnology
5.8.1 Nurotron Biotechnology Profile
5.8.2 Nurotron Biotechnology Main Business
5.8.3 Nurotron Biotechnology Pendred Syndrome Products, Services and Solutions
5.8.4 Nurotron Biotechnology Pendred Syndrome Revenue (US$ Million) & (2018-2023)
5.8.5 Nurotron Biotechnology Recent Developments
5.9 GN Store Nord
5.9.1 GN Store Nord Profile
5.9.2 GN Store Nord Main Business
5.9.3 GN Store Nord Pendred Syndrome Products, Services and Solutions
5.9.4 GN Store Nord Pendred Syndrome Revenue (US$ Million) & (2018-2023)
5.9.5 GN Store Nord Recent Developments
5.10 Audina Hearing Instruments
5.10.1 Audina Hearing Instruments Profile
5.10.2 Audina Hearing Instruments Main Business
5.10.3 Audina Hearing Instruments Pendred Syndrome Products, Services and Solutions
5.10.4 Audina Hearing Instruments Pendred Syndrome Revenue (US$ Million) & (2018-2023)
5.10.5 Audina Hearing Instruments Recent Developments
5.11 Rion
5.11.1 Rion Profile
5.11.2 Rion Main Business
5.11.3 Rion Pendred Syndrome Products, Services and Solutions
5.11.4 Rion Pendred Syndrome Revenue (US$ Million) & (2018-2023)
5.11.5 Rion Recent Developments
5.12 Starkey
5.12.1 Starkey Profile
5.12.2 Starkey Main Business
5.12.3 Starkey Pendred Syndrome Products, Services and Solutions
5.12.4 Starkey Pendred Syndrome Revenue (US$ Million) & (2018-2023)
5.12.5 Starkey Recent Developments
6 North America
6.1 North America Pendred Syndrome Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Pendred Syndrome Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pendred Syndrome Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pendred Syndrome Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pendred Syndrome Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pendred Syndrome Market Dynamics
11.1 Pendred Syndrome Industry Trends
11.2 Pendred Syndrome Market Drivers
11.3 Pendred Syndrome Market Challenges
11.4 Pendred Syndrome Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
